Elizabeth Holmes is back in the spotlight: why can’t we look away?
Oct 22, 2026 · 17m
More Science podcasts
Summary
This episode examines the Theranos scandal and Elizabeth Holmes’s recent return to the spotlight via a new documentary. Host Madeleine Finlay and tech editor Blake Montgomery discuss how Holmes’s charismatic persona and Silicon Valley’s “fake it till you make it” culture allowed a fraudulent blood-testing company to reach a $9 billion valuation before crashing. The conversation explores the clash between slow scientific validation and rapid startup growth, noting that the lack of serious healthcare investors contributed to the fraud.
Topics discussed
Show intro
Verizon Fios ad
Whole Foods Market ad
Theranos lab test ad
Episode intro: Theranos and Elizabeth Holmes
Origin story: Holmes and the rise of Theranos
The collapse: Employee whistleblowing and fraud
Why it lasted: Silicon Valley culture vs. healthcare
Science vs. startup culture and lack of scrutiny
Lessons learned? AI bubble and 'fake it till you make it'
Billy Evans' new startup and consumer trust
Promo: Radical Thinking with James Graham
Thomson Reuters ad
Impact on women in biotech and tech
Why we are fascinated by Elizabeth Holmes
Tech journalism accountability and future outlook
Promo: NASA documentary
Credits and sign-off
Charles Schwab ad
Verizon Fios ad (repeat)
Thomson Reuters ad (repeat)
More from Science Weekly
Listen ad-free on Castria